Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11673944 Treatment of tauopathies

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
TAUC3 Biologics Ltd
0
Date Filed
January 14, 2021
0
Date of Patent
June 13, 2023
0
Patent Applicant
‌
TAUC3 Biologics Ltd
0
Patent Application Number
17148690
0
Patent Citations
‌
US Patent 7737138 Methods of treatment of a tauopathy condition comprising the use of thioninium compounds
0
‌
US Patent 7790881 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC)
0
‌
US Patent 7834237 Materials and methods relating to protein aggregation in neurodegenerative disease
0
‌
US Patent 8012936 Tau fragments for immunotherapy
0
‌
US Patent 7901689 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
0
‌
US Patent 7238788 Antibodies to phosphorylated tau, methods of making and methods of use
0
‌
US Patent 7488727 Thiazole compounds useful as inhibitors of protein kinase
0
‌
US Patent 7534786 Inhibition of tau-tau association
0
‌
US Patent 7605179 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
0
‌
US Patent 7713962 Neurofibrillary labels
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11673944
0
Patent Primary Examiner
‌
Adam Weidner
0

Find more entities like US Patent 11673944 Treatment of tauopathies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.